By Anton Ladnyi, CFA · ex-Goldman Sachs · ex-J.P. MorganPublished Updated
ASML — the world's only EUV supplier facing its most complex narrative: TSMC delayed High-NA EUV adoption to at least 2029 (Low-NA through nodes A12/A13), triggering Jefferies and Barclays downgrades to Neutral (May 15); MATCH Act (bipartisan) would cut DUV sales to SMIC/YMTC/ChangXin/Hua Hong/Huawei — China already fell from 36% to 19% of net system sales in one quarter; offset by Intel 18A deployment, Samsung's second High-NA machine in H1 2026, and €8B+ orders from SK Hynix/Samsung; €38.8B backlog, €36–40B full-year guidance maintained.
ASML Price Target & Rating
ASML's quantitative grade is Avoid, with moderate downside risk (CVaR -12.9%), and quality metrics (net margin 30%, ROE 52%). ASML Holding N.V. (ASML) trades at $1,777.77 with a valuation grade of Avoid: a trailing P/E of 58.1x at a 82% premium to sector median, net margins of 29.7%, a DCF-implied intrinsic range of $774–$1,894 suggesting a -25% margin of safety, beta 1.40 (moderate risk profile).
DCF Valuation Range
Key Takeaways
Valuation: Avoid grade — P/E 58.1x — DCF range $774–$1,894 implies -25% margin of safety
Risk: CVaR -12.9% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.40 amplifies broad market moves in both directions
Strengths: Quality 5.0/5, Size 4.5/5, 30% net margin, 52% ROE dominate the factor profile
Catalyst: Q2 2026 earnings (July) — bookings update (whether €38.8B holds), High-NA delivery schedule, MATCH Act legislative progress and Netherlands government response
Bear catalyst: Dutch or US government extends DUV export restrictions to China; Q2 bookings decline below €5B signaling customer pull-forward exhaustion; High-NA EUV yield ramp delayed at TSMC or Intel beyond H1 2027; ASML lowers FY2026 guidance below €35B
ASML — Quantitative SnapshotJune 2026
RatingAvoid
Price$1,777.77
Why AvoidTrading at a significant premium to intrinsic value — DCF and analyst consensus suggest limited margin of safety; valuation risk outweighs near-term upside
Main riskP/E of 58.1x creates asymmetric downside on any earnings disappointment
Tail riskCVaR -12.9% over one month at the 95th percentile
DCF range$774–$1,894 intrinsic range; margin of safety -25%
Best useCore mega-cap Technology holding — not a source of diversified sector exposure
Next watchEarnings delivery consistency and margin trajectory
Quantitative Factor Profile
Value
2.0 / 5
Quality
5.0 / 5
Momentum
3.0 / 5
Volatility
2.5 / 5
Size
4.5 / 5
Key Metrics
ASML Key Metrics — ASML Holding N.V. 2026
Metric
Value
Current Price
$1,777.77
P/E Ratio (TTM)
58.1x
Forward P/E
36.2x
PEG Ratio
1.89x
P/S Ratio
19.8
EV/EBITDA
2,922.2
Beta
1.40
Net Margin
29.7%
ROE
52.2%
Debt/Equity
13.0%
Dividend Yield
0.51%
CVaR (95%, 1M)
-12.9%
Market Cap
$668.4B
Analyst View
Anton Ladnyi, CFA · A.L. Capital AdvisoryUpdated 2026-06-11
Rating Rationale
ASML — the world's only EUV supplier facing its most complex narrative: TSMC delayed High-NA EUV adoption to at least 2029 (Low-NA through nodes A12/A13), triggering Jefferies and Barclays downgrades to Neutral (May 15); MATCH Act (bipartisan) would cut DUV sales to SMIC/YMTC/ChangXin/Hua Hong/Huawei — China already fell from 36% to 19% of net system sales in one quarter; offset by Intel 18A deployment, Samsung's second High-NA machine in H1 2026, and €8B+ orders from SK Hynix/Samsung; €38.8B backlog, €36–40B full-year guidance maintained.
Investment Thesis
↑ Bull Case
Structural monopoly with no credible competitor within a decade: EUV lithography requires €17B+ in cumulative R&D over 30 years and a global supply chain of 5,000+ components — ASML's only real competitor (Nikon) exited EUV; no Chinese or Korean alternative exists; every chip at 7nm and below requires ASML equipment, making revenue growth a function of industry capex not competitive dynamics
High-NA EUV (TWINSCAN NXE:3800E) is the next mandatory upgrade for A14/A16/2nm production: the first High-NA systems are shipping to TSMC and Intel; at €350M+ per unit vs. €200M for Low-NA EUV, the ASP uplift per system sold is ~75%; as leading-edge fabs ramp High-NA, ASML's revenue per customer accelerates without volume needing to increase proportionally
Full-year 2026 guidance raised to €36–40B (from €34–39B) and EUV Low-NA output target lifted to 60 systems in 2026 / 80+ in 2027: this is not demand anticipation — ASML ships against confirmed customer POs with multi-year lead times; the raised targets reflect orders already booked
Installed Base revenues of €2.5B/quarter are a structural recurring cash flow stream growing at 15%+ annually as the number of EUV systems in the field compounds: service contracts, upgrades, and spare parts create a quasi-SaaS annuity on top of the capital equipment cycle, dampening revenue volatility
China remains ~20% of revenue and no further DUV restrictions have been implemented: while China cannot access EUV, DUV systems continue to be legal to ship; Chinese fabs are aggressively buying DUV to maximize production at mature nodes, providing a structural demand buffer even if EUV access is permanently restricted
Intel is deploying High-NA EUV on 14A; Samsung received its first High-NA machine (second installing H1 2026) — partially offsetting the TSMC delay; SK Hynix and Samsung placed €8B+ in EUV orders for HBM memory demand, sustaining the order book independent of logic node progression
Bernstein argues TSMC delay is 'probably neutral or even positive' — TSMC may order more Low-NA EUV to substitute; €38.8B backlog provides 2+ years of revenue visibility; EUV build rate 60+ systems in 2026 (36% above 5-year average), targeting 80 units in 2027
Elon Musk's $55B Terafab AI chip manufacturing push (June 2026) places ASML at center of AI chip supply race — any new US fab buildout requires High-NA EUV machines, of which ASML is sole supplier
↓ Bear Case
Export restrictions on DUV to China are the highest-consequence near-term risk: if the US/Netherlands government extends EUV-style restrictions to immersion DUV systems, ASML loses ~20% of revenue with no short-term replacement customer pool; China has been the key volume buyer sustaining DUV revenue through 2025–2026
EUV shipment concentration creates lumpy quarterly revenue: €8.8B in Q1 represents 67 systems — a shift of 5–7 systems between quarters due to customer qualification delays creates 8–12% revenue variance that drives outsized stock volatility despite zero change in underlying demand
High-NA EUV adoption timeline is uncertain: TSMC has indicated it will use High-NA only selectively for the most advanced process layers through 2026–2027, while Samsung and Intel face yield challenges; if High-NA ramp is slower than expected, ASP uplift materializes 2–3 years later than consensus models assume
At €1,371 / $1,525 and ~50x forward P/E, ASML prices in near-perfect execution of the 2030 targets: ASML's own long-range planning scenarios target €44–60B in 2030 revenue — the low end of that range at current multiples barely supports the current price; any 2030 outlook revision sends a disproportionate signal
TSMC High-NA EUV delay to 2029 removes the primary near-term margin driver: TSMC is the world's largest advanced-node customer; its decision to use Low-NA EUV through A12/A13 creates a 3-year gap in the High-NA adoption curve that ASML cannot force; Jefferies and Barclays both downgraded to Neutral on May 15 — three analyst downgrades in two weeks
MATCH Act (bipartisan US bill): 150-day window for Netherlands/Japan to tighten controls before unilateral US action; if DUV sales to Chinese customers are blocked, the remaining ~19% of net system sales is at risk; Netherlands government faces political pressure to comply or face US sanctions
China DUV export restriction risk intensifying: HSBC flagged chip price slide + AI spending slowdown concerns; ASML fell -6.5% on Q1 earnings as expectations outpaced results; China revenue shrinkage from DUV restrictions is an accelerating headwind
What Changes the Rating
↑Catalyst:Q2 2026 EUV bookings exceed €10B; High-NA EUV system deliveries confirmed above 5 units for H2 2026; FY2026 revenue guidance raised to the high end of the €36-40B range; Intel 18A yield improvement confirms High-NA demand thesis
↓Stop / exit:Dutch or US government extends DUV export restrictions to China; Q2 bookings decline below €5B signaling customer pull-forward exhaustion; High-NA EUV yield ramp delayed at TSMC or Intel beyond H1 2027; ASML lowers FY2026 guidance below €35B
Anton’s personal note
The rating on ASML is driven by a factor profile that is genuinely mixed — there is no clean narrative here, which is itself a signal worth taking seriously. What I pay attention to above all else is the earnings surprise trajectory. The beat streak is intact, but the magnitude has compressed from +12.4% to +8.0% — and at a 58x multiple, the market is not pricing in a miss. That asymmetry is worth respecting. The scenario that changes my read is a genuine valuation reset — not a small pullback, but a re-rating that reflects the actual risk profile. Until that happens, the risk/reward is not there.
— Anton Ladnyi, CFA
Earnings History
ASML Earnings History — EPS Surprise Rate 2026
Quarter
EPS Est.
EPS Actual
Surprise
Q1 2026
$6.62
$7.15
+8.0% ✓
Q4 2025
$7.55
$7.34
-2.7% ✗
Q3 2025
$5.37
$5.49
+2.1% ✓
Q2 2025
$5.25
$5.90
+12.4% ✓
Quarterly EPS — Estimate vs Actual
Earnings Projections
ASML Forward EPS Consensus Estimates 2026
Quarter
EPS Est.
YoY EPS
Analysts
Q2 2026
$6.85
+16.1%
14
Q3 2026
$8.30
+51.2%
12
Q4 2026
~$9.17
+24.9%
34
Q1 2027
~$10.36
+44.9%
33
~ Estimated from annual consensus — not a direct analyst survey
ASML — P/E 58.1x · Beta 1.40 • Quantitative grade: Avoid • CVaR from one-year daily history · historical simulation
DCF Scenario Analysis
Hover each scenario for detail · current price $1,777.77
▼
Bear Case
$850
-52.2%
Fwd P/E: 24.5x
8% revenue CAGR · 28x exit multiple
◆
Base Case
$1,620
-8.9%
Fwd P/E: 46.7x
14% revenue CAGR · 45x exit multiple
▲
Bull Case
$2,400
+35.0%
Fwd P/E: 69.2x
20% revenue CAGR · 58x exit multiple
Pairwise Correlation Matrix
2 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.
Is ASML a buy, hold, or sell?
ASML carries a valuation grade of Avoid. The trailing P/E of 58.1 sits 82% above the Technology sector median of 32.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $774–$1,894 — implying a -25% margin of safety at the current price of $1,777.77. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 8.0% earnings surprise. Analyst estimate revisions are trending upward.
What are ASML's key risk factors?
With a beta of 1.40, ASML exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -12.9% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.3% of total portfolio loss in the worst 5% of months. Net margins of 29.7% are significantly above the Technology sector average of 22%, reflecting durable pricing power. Return on equity of 52.2% indicates highly efficient capital allocation. The balance sheet is conservatively leveraged at 13% debt-to-equity.
Short interest is low at 0.3% of float, suggesting limited bearish conviction.
How does ASML fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — ASML carries a beta of 1.40, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, ASML shows the strongest co-movement with TSM (0.65), NVDA (0.49), AMD (0.47). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The ASML analysis here is a single node in that larger structure.
ASML Holding N.V. (ASML) carries a Avoid quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $1,777.77, the DCF midpoint margin of safety is -25% (intrinsic value range: $774 bear – $1,894 bull). Composite factor score: 3.4/5. Strongest factor: Quality (5.0/5). Weakest factor: Value (2.0/5). Trailing P/E: 58.1x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →
What is the average analyst target price for ASML?
Wall Street consensus target for ASML: $1,696.22 (-4.6% downside from the current price of $1,777.77). The analyst target range spans $892.32 (most bearish) to $2,253.61 (most bullish). Consensus recommendation: Strong Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Avoid rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →
How does ASML score on Value, Quality, Momentum, Volatility, and Size?
ASML five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 2.0/5 (below average) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 5.0/5 (strong) — captures profitability metrics including return on equity, net margin (ROE: 52.2%) and net margin (29.7%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 2.5/5 (neutral) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.5/5 (strong) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.4/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →
What is ASML's tail risk and CVaR?
The 95th-percentile Conditional Value at Risk (CVaR) for ASML on a one-month horizon is -12.9%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 1.40 indicates above-market volatility with amplified drawdown exposure. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →
What is ASML's intrinsic value and DCF price target?
A.L. Capital Advisory's DCF model produces an intrinsic value range of $774 (bear case) to $1,894 (bull case) for ASML Holding N.V. (ASML). At $1,777.77, the midpoint margin of safety is -25% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →
What would trigger a rating upgrade or downgrade for ASML?
Upgrade trigger: Upgrade to Strong Buy on evidence of accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 58.1x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: Continued earnings misses or deteriorating balance sheet quality reducing the Quality factor score below 2.0/5. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →
Does ASML consistently beat earnings estimates?
ASML has beaten consensus EPS estimates in 9% of tracked quarterly periods — indicating inconsistent delivery. The most recent reported quarter beat consensus by 8.0%. Below-average earnings consistency is a primary headwind to the rating and a key watch item in the quantitative model. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →
How does ASML contribute to portfolio risk and diversification?
ASML carries a beta of 1.40 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: TSM (0.65), NVDA (0.49), AMD (0.47). Holding ASML alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →
What quantitative methodology does A.L. Capital Advisory use to analyse ASML?
A.L. Capital Advisory analyses ASML Holding N.V. (ASML) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Avoid rating for ASML is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework → · CVaR & Tail-Risk Methodology →
Stress-Test This View Live
Run ASML in Asset Lens
Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.
This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-06-11 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with ASML Holding N.V.
CFA Portfolio Advisory — ASML
Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.
